Natives Engaged in Alzheimer's Research - 'Ike Kupuna
This study, called 'Ike Kupuna, is testing a hula-based program called Ola Mau i ka Hula. This program involves hula lessons and education about Alzheimer's disease and related dementias (ADRD). The study aims to see if this program can improve risk factors for ADRD, such as blood pressure, A1c (a measure of blood sugar), and cholesterol, as well as cognitive complaints and function over 12 months. You may be able to join if you are a Native Hawaiian or other Pacific Islander, between 50 and 75 years old, and have subjective cognitive impairment (SCI) or mild cognitive impairment (MCI). The study is currently unclear about its recruitment status.
- Study design
- This is an interventional study planning to enroll 192 participants. It uses a group-randomized design, meaning groups of people will be assigned to either receive the hula intervention or be in a control group.
- What's involved
- Participants will engage in a hula-based intervention program for 3 months, which includes hula lessons and ADRD education. Measurements for blood pressure and cholesterol will be taken at 3, 8, and 12 months, and A1c will be measured at 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after starting the study, with measurements taken at 3, 8, and 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Natives Engaged in Alzheimers Research - 'Ike Kupuna
At a glance
Conditions
Where it's being run
3 sites across 1 statesStudy leadership
- Joseph K Kaholokula, PhD · PRINCIPAL_INVESTIGATOR · University of Hawaii
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in participants' systolic blood pressure at each time frame from baseline3 months, 8 months, 12 months
Vascular risk factor assessed using Omron©HEM-907XL
- Change in participants' Hemoglobin A1c at each time frame from baseline12 months
Vascular risk factor assessed using Alere Cholestech LDX® System
- Change in participants' total cholesterol at each time frame from baseline3 months, 8 months, 12 months
Vascular risk factor assessed using Alere Cholestech LDX® System
- Change in participants' body mass index at each time frame from baseline3 months, 8 months, 12 months
Vascular risk factor assessed using Tanita BWB800AS scale
- Change in participants' Cognitive Change Index score at each time frame from baseline3 months, 8 months, 12 months
Cognitive function assessed using Cognitive Change Index assessment
- Change in participants' Number Symbol Coding Test score at each time frame from baseline3 months, 8 months, 12 months
Cognitive function assessed using Number Symbol Coding Test
- Change in participants' overall Cognivue score at each time frame from baseline3 months, 8 months, 12 months
Cognitive function assessed using Cognivue device
- Change in participants' overall Quick Dementia Rating System score at each time frame from baseline3 months, 8 months, 12 months
Cognitive function assessed using Quick Dementia Rating System assessment